The concept was that BPC 157, given before or immediately after succinylcholine, counteracted succinylcholine effects [102]
Other indicators of insufficient dosing include: No change in body weight after four or more weeks at the same dose Hunger returning well before your next weekly injection, especially if it returns within two to three days No change in blood sugar levels for individuals using tirzepatide for type 2 diabetes Food noise remaining as loud as it was before starting the medication If you are reading this because you drew 50 units from a 5 mg/mL vial and are wondering why you are not losing weight on tirzepatide , the answer may simply be that 2.5 mg is the initiation dose, not a weight-loss dose
By analogy with semaglutide (where the STEP-4 withdrawal trial demonstrated substantial weight regain within 12 months of discontinuation), researchers should anticipate that weight regain is likely following cessation of any GLP-1 class compound, including retatrutide
Its great, he has said, you recover fast. Peptides are all the rage, but everything about them is confusing
As of May 2026, BPC-157 isnt FDA-approved and sits on the FDAs restricted (Category 2) compounding list, so selling it as a drug or supplement is illegal (source)
